Raptor’s Rare Disease Drug Procysbi Gets CHMP Green Light In Europe
The European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion regarding Raptor Pharmaceutical Corporation’s drug,
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓